特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
391454

世界のOTC鎮痛薬市場 - 成長、動向、予測

Over the Counter (OTC) Analgesics Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 114 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
世界のOTC鎮痛薬市場 - 成長、動向、予測
出版日: 2020年08月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 114 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のOTC鎮痛薬市場は、プレミアムブランド製品のパフォーマンスの向上や、プライベートラベル製品の売上率の上昇などによって成長が促進されています。

当レポートでは、世界のOTC鎮痛薬市場について調査し、市場の概要、製品タイプ・地域別の市場動向、市場規模の推移と予測、市場成長・阻害要因ならびに市場機会・課題の分析、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査の成果
  • 市場の定義
  • 調査対象期間と予測
  • 一般調査の前提条件
  • レポートの説明

第2章 調査方法

  • イントロダクション
  • 分析方法論
  • 調査のタイムライン
  • 調査のフェーズ
    • 2次調査
    • ディスカッションガイド
    • マーケットエンジニアリング&計量経済学モデル

第3章 エグゼクティブサマリー

第4章 主要なインパレント

第5章 市場概要および産業動向

  • 市場概況
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 市場力学

  • 市場成長要因
    • プレミアムブランド製品のパフォーマンス向上
    • 高性能なPB鎮痛薬
  • 市場阻害要因
    • 連続的な服用による副作用
  • 市場機会
    • 統合的な局所および全身治療の革新
  • 主な課題

第7章 世界のOTC鎮痛薬市場:市場区分

  • 薬品タイプ別
    • アセトアミノフェン(タイレノール)
    • 非ステロイド系抗炎症薬
    • サリチル酸塩

第8章 世界のOTC鎮痛薬市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン・ポルトガル
    • スカンジナビア諸国
    • ベネルクス諸国
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア・ニュージーランド
    • 韓国
    • その他
  • 中東・アフリカ
    • 湾岸協力会議(GCC)
    • 南アフリカ
    • その他
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他

第9章 競合情勢

  • M&A分析
  • 新製品の発売
  • 合意、コラボレーション、パートナーシップ

第10章 企業プロファイル

  • Bayer
  • Sanofi
  • Boehringer Ingelheim
  • Novartis
  • Johnson & Johnson
  • 武田薬品
  • Sun Pharma
  • Others

第11章 アナリストによる投資機会の見通し

第12章 市場の将来展望

目次
Product Code: 52583

The major factors boosting the growth of the market studied include the increasing demand in topical analgesics, growth in the geriatric population resulting in the rising prevalence of various diseases, and the cost-efficiency of OTC analgesics drugs.

  • According to the estimates by the American Academy of Pain Medicine, over 100 million Americans suffer from chronic pain, every year.
  • With the growing aging population, the demand for pain relief solutions is increasing, as aged people are more prone to chronic pain.
  • According to the United Nations' report in 2017, there were an estimated 962 million people aged 60 years or over in the world, comprising 13% of the global population. The population aged 60 years or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 years or over, as per 2017.
  • Rapid aging is expected in other parts of the world. Owing to this, all regions of the world, except Africa, are expected to have nearly a quarter or more of their populations aged at 60 years and above, by 2050.
  • According to the estimates of the United Nations' report in 2017, the total number of aged population in the world was projected to reach 1.4 billion in 2030 and 2.1 billion in 2050, approximately, and it is likely to rise to 3.1 billion in 2100. Thus, the growth in the geriatric population is driving the growth of the global OTC analgesics market.

Key Market Trends

Retail Pharmacies Segment by Distribution Channel is Expected to Dominate the Market

OTC medicines are conveniently sold in several retail outlets, including those without pharmacies, and they are easily available. In the United States, there are more than 750,000 retail establishments nationwide, and both rural and urban consumers have 24/7 access to treatments for common, everyday conditions. Furthermore, most of the patients are preferring self medications without consulting a doctor or a pharmacist. However, the hospital pharmacies segment is expected to maintain a relatively low growth rate in terms of revenue generated through distribution of OTC drugs, as mostly the sale of OTCs takes place in case of non-prescribed drugs, and it is relatively easy for most consumers to acquire these drugs either from retail pharmacies or online pharmacies. Thus, owing to the rising geriatric population, affordability, and high accessibility of OTC analgesics, the market is expected to witness rapid growth over the forecast period.

North America is Expected to Dominate the Market

According to the Consumer Healthcare Products Association, 2019, it was estimated that about 93% of the Americans prefer to treat their minor ailments with OTC medicines before seeking professional care. Chronic pain has been linked to several physical and mental conditions, and contributes to high healthcare costs and lost productivity. In 2016, approximately 20.4% of adults in the United States had chronic pain, and 8.0% had high-impact chronic pain. Both kinds of pain were more widespread among adults living in poverty, adults with less than high school education, and adults with public health insurance. For the treatment of musculoskeletal injuries and disorders, many patients in the United States generally use non-prescription topical analgesics. Hence, with the increase in the prevalence of chronic pain, the demand for OTC analgesics is expected to increase, which is likely to drive the market over the forecast period.

Competitive Landscape

The market studied is fragmented in nature, owing to the presence of many small and large market players. Some of the major players are Bayer AG, Boehringer Ingelheim International GmbH, Johnson & Johnson, GlaxoSmithKline PLC, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi SA, Sun Pharmaceutical Industries Ltd, and Takeda Pharmaceutical Company Limited.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand in Topical Analgesics
    • 4.2.2 Growth in the Geriatric Population Resulting in the Rising Prevalence of Various Diseases
    • 4.2.3 Cost Efficiency of OTC Analgesics Drugs
  • 4.3 Market Restraints
    • 4.3.1 Drug Tolerance, Dependence, and Addiction and Abuse​
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Drug
    • 5.1.1 Acetaminophen
    • 5.1.2 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 5.1.3 Salicylates
    • 5.1.4 Other Analgesics​
  • 5.2 By Distribution Channel
    • 5.2.1 Hospital Pharmacies
    • 5.2.2 Retail Pharmacies
    • 5.2.3 Online Pharmacies
    • 5.2.4 Others Distribution Channels
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bayer AG
    • 6.1.2 Boehringer Ingelheim International GmbH
    • 6.1.3 Johnson & Johnson
    • 6.1.4 GlaxoSmithKline PLC
    • 6.1.5 Pfizer Inc.
    • 6.1.6 Reckitt Benckiser Group PLC
    • 6.1.7 Sanofi SA
    • 6.1.8 Sun Pharmaceutical Industries Ltd
    • 6.1.9 Takeda Pharmaceutical Company Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.